FDA Approves Feasibility Study With Seastar Medical'S Selective Cytopheretic Device In Adults With Cardiorenal Syndrome

  • Kevin Chung

Press/Media

Period13 Jan 2025

Media coverage

1

Media coverage

  • TitleFDA Approves Feasibility Study With Seastar Medical'S Selective Cytopheretic Device In Adults With Cardiorenal Syndrome
    Media name/outletMENAFN -Press Releases (English)
    Country/TerritoryJordan
    Date13/01/25
    PersonsKevin Chung
View all 1
View less